BlackRock Health Sciences Trust II (BMEZ) Overview

BlackRock Health Sciences Trust II(BMEZ)

USD --+0.00%

Reward50Moderate

Risk17Low

📊75%Data

BMEZ

+0.0 · +0.00%

USD · NYSE

BlackRock Health Sciences Trust II | Financial Services

Defensive Anchor

Market Cap:875.64M

ℹ️

Reward Rating

Moderate

Bottom 50% (model universe)

75% data coverage

ℹ️

Risk Rating

Low

Risk Assessment

Limited data coverage

We don't have enough public data on BMEZ to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

BMEZ · Verdict

Moderate reward · low risk

BMEZ stands out on balance sheet and volatility, but watch the growth signal.

Based on 88% data coverage

BMEZ · Verdict

What’s working & what to watch

Strengths 5

Balance sheet98/100
Interest covered 313228.0×
Volatility95/100
Top decile vs peers
Profitability69/100
97% net margin · 0% ROE
Valuation68/100
Above average
Cash flow66/100
272% free-cash-flow margin

Watchouts 1

Growth34/100
Rev -26.1% CAGR · earnings -26.5%

Model-based scoring. For information only — not financial advice.

What is BlackRock Health Sciences Trust II?

No description available.

Financial Highlights

Investment Breakdown

📈 Growth

Moderate growth momentum — positive trajectory without breakout acceleration.

💰 Profitability

Adequate profitability with some margin variability in recent periods.

⚠️ Risk

Below-average volatility supports a steadier risk profile.

💸 Valuation

Valuation appears fair relative to current fundamentals.

Analysis

Reward: Moderate (50)

The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.